A Nanobody-Based Lateral Flow Assay for Point-of-Care Diagnostics
Biosensors · 22.02.2026 · 16 (2) · 132
DOI: 10.3390/bios16020132 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors, online erschienen am 22.02.2026. Verfasst von Timothy A Bates und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Microbiology and Immunology, Oregon Health & Sciences University, Portland, OR 97239, USA. Hauptthemen laut MEDLINE: Single-Domain Antibodies, SARS-CoV-2, Biosensing Techniques, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, US National Institutes of Health, Silver Innovation Award.
Abstract (Originalsprache)
Lateral flow assays (LFAs) are among the most successful technologies for point-of-care and at-home testing, but further advances are needed to reduce costs and accelerate development. Alpaca-derived nanobodies (Nbs), single-domain antibody fragments, are promising immunoassay reagents across diverse applications. Their small size and ease of recombinant production make them particularly well suited for diagnostics. Here, we present a paper-based LFA targeting the SARS-CoV-2 nucleocapsid (N) protein that exclusively uses Nbs for direct antigen detection. We also demonstrate in-house synthesis of Nb-coated gold nanoparticles, enabling instrument-free visual readout and detection of N protein down to 40 ng/mL. This design avoids components that require mammalian cell culture and can be produced entirely from in-house reagents, simplifying manufacturing and lowering component costs. Because the assay is read visually without an external reader, it is well suited for deployment in resource-limited settings. Together, these results highlight the speed and practicality of developing Nb-based LFAs and suggest a broadly applicable strategy for detecting other clinically important disease biomarkers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Microbiology and Immunology, Oregon Health & Sciences University, Portland, OR 97239, USA.
- Department of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR 97239, USA.
ORCID-Profile: Timothy A Bates, Fikadu G Tafesse
Förderung
- NIAID NIH HHS
- US National Institutes of Health
- Silver Innovation Award
- Oregon Health & Science University Biophysics Shared Resources Core and equipment
Zitieren
APA
Bates, T. A., Gurmessa, S. K., Reyes-Weinstein, J. B., Barklis, E., & Tafesse, F. G. (2026). A Nanobody-Based Lateral Flow Assay for Point-of-Care Diagnostics. Biosensors, 16(2), 132. https://doi.org/10.3390/bios16020132
Vancouver
Bates TA, Gurmessa SK, Reyes-Weinstein JB, Barklis E, Tafesse FG. A Nanobody-Based Lateral Flow Assay for Point-of-Care Diagnostics. Biosensors. 2026;16(2):132. doi:10.3390/bios16020132
BibTeX
@article{Bates2026,
author = {Bates, Timothy A and Gurmessa, Sintayehu K and Reyes-Weinstein, Jules B and Barklis, Eric and Tafesse, Fikadu G},
title = {A Nanobody-Based Lateral Flow Assay for Point-of-Care Diagnostics},
journal = {Biosensors},
year = {2026},
volume = {16},
number = {2},
pages = {132},
doi = {10.3390/bios16020132}
}
EUVIMED